MARCH 31, 2022

The Regueiro Report: Optimizing Anti-TNF Treatment for IBD

Miguel Regueiro, MD
Professor of Medicine
Chair of the Digestive Disease & Surgery Institute
Cleveland Clinic, Cleveland
image

This month, I’m focusing on how to optimize anti-TNF treatment decisions.

The first topic I chose to look at is the use of proactive therapeutic drug monitoring (TDM). Based on limited data, the practice is thought to improve outcomes, but the trial I’ve highlighted—which included patients with IBD and other illnesses treated with infliximab—showed that